Furthermore, we explore how activated SLC26A4 is associated with various human diseases, including CRSwNP, COPD, asthma, cystic fibrosis, lung injury, hypertension, and renal acid-base homeostasis. This evidence concerns the gene SLC26A4 and chronic obstructive pulmonary disease.